Inventor · disambiguated record
Anthony Bolton
Also filed as: BOLTON ANTHONY · BOLTON ANTHONY E · BOLTON ANTHONY ERNEST
18 granted patents·35 pending applications·449 citations·filing 1989–2020
95Inventor score
Files withVASOGEN IRELAND LTD26CARDIOL THERAPEUTICS INC4VASOGEN INC3LYNCH MARINA A2BOLTON ANTHONY E1
Top patents by PatentIndex Score
53 records- 0189US5980954ATreatment of autoimmune diseasesVASOGEN IRELAND LIMITED·Filed 1996·Granted Nov 9, 1999·92 cites·12 claims
- 0285US5834030AMethod of increasing the concentration of nitric oxide in human bloodVASOGEN INC·Filed 1995·Granted Nov 10, 1998·78 cites·12 claims
- 0379US5039521AImmune cell proliferation inhibitorsHYAL PHARMA CORP·Filed 1989·Granted Aug 13, 1991·21 cites·21 claims
- 0476US6569467B1Treatment of autoimmune diseasesVASOGEN IRELAND LTD·Filed 1999·Granted May 27, 2003·34 cites·4 claims
- 0573US7255880B2Treatment of endothelin-related disordersVASOGEN IRELAND LTD·Filed 2004·Granted Aug 14, 2007·4 cites·19 claims
- 0672US6986888B1Method for treating mammals with modified mammalian bloodVASOGEN IRELAND LTD·Filed 2000·Granted Jan 17, 2006·5 cites·6 claims
- 0770US7122208B2Compositions containing apoptotic entitiesVASOGEN IRELAND LTD·Filed 2002·Granted Oct 17, 2006·5 cites·28 claims
- 0868US6953591B2Apoptosis-mimicking synthetic entities and use thereof in medical treatmentVASOGEN IRELAND LTD·Filed 2001·Granted Oct 11, 2005·4 cites·10 claims
- 0963US6086552ATreatment of chronic post-traumatic pain syndromesVASOGEN INC·Filed 1998·Granted Jul 11, 2000·24 cites·7 claims
- 1062US7279156B2Apoptotic entities for use in treatment of endothelium dysfunction disordersVASOGEN IRELAND LTD·Filed 2001·Granted Oct 9, 2007·2 cites·14 claims
- 1162US6669965B2Method of treating atherosclerosisVASOGEN IRELAND LTD·Filed 1999·Granted Dec 30, 2003·23 cites·9 claims
- 1261US7597906B2Apoptosis-mimicking synthetic entities and use thereof in medical treatmentVASOGEN IRELAND LTD·Filed 2007·Granted Oct 6, 2009·0 cites·5 claims
- 1359US5256411AImmune cell proliferation inhibitorsINTERMUNE LIFE SCIENCES INC·Filed 1991·Granted Oct 26, 1993·14 cites·28 claims
- 1459US2008166400A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 1559US2008160074A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 1659US2008171082A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 1759US2008124386A1Apoptosis-mimicking synthetic entities and use thereof in medical treatmentVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 1859US2008171081A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesBOLTON ANTHONY ERNEST·Filed 2007·Application pending·0 cites
- 1958US6204058B1Treatment of autoimmune diseasesVASOGEN IRELAND LTD·Filed 1999·Granted Mar 20, 2001·80 cites·8 claims
- 2058US2008075764A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 2155US2005037063A1Combined therapiesFiled 2004·Application pending·0 cites
- 2255US2008131416A1Apoptotic entities for use in treatment of neurodegenerative and other neurological disordersVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 2355US2005058698A1Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's DiseaseFiled 2004·Application pending·0 cites
- 2454US7223391B2Method for treating mammals with modified mammalian bloodVASOGEN IRELAND LTD·Filed 2005·Granted May 29, 2007·0 cites·5 claims
- 2554US2005123598A1Apoptosis-mimicking synthetic entities and use thereof in medical treatmentVASOGEN IRELAND LTD·Filed 2005·Application pending·0 cites
- 2654US2022347118A1Stable medicinal cannabidiol compositionsCARDIOL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2754US2024139216A1Stable oral cannabidiol compositionsCARDIOL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2853US2007087010A1Apoptotic entities for use in treatment of neurodegenerative and other neurological disordersVASOGEN IRELAND LTD·Filed 2006·Application pending·0 cites
- 2952US2006105031A1Accelerating recovery from traumaVASOGEN IRELAND LTD·Filed 2003·Application pending·0 cites
- 3051US2004013718A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesFiled 2003·Application pending·0 cites
- 3151US2008063631A1Apoptotic entities for use in treatment of endothelium dysfunction disordersVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 3251US2003157114A1Treatment of autoimmune diseasesFiled 2003·Application pending·0 cites
- 3351US2003175334A1Phospholipid bodies and use thereof in medical treatmentFiled 2003·Application pending·0 cites
- 3450US5591457AMethod of inhibiting the aggregation of blood platelets and stimulating the immune systems of a humanVASOGEN INC·Filed 1994·Granted Jan 7, 1997·60 cites·9 claims
- 3550US2005147660A1Peptide-carrying bodies for immune responseFiled 2003·Application pending·0 cites
- 3649US2005058767A1Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entitiesFiled 2002·Application pending·0 cites
- 3747US7132285B2Apoptotic entities for use in treatment of neurodegenerative and other neurological disordersVASOGEN IRELAND LTD·Filed 2001·Granted Nov 7, 2006·0 cites·4 claims
- 3847US2004101517A1Blood brain barrier modulation using stressed autologous blood cellsFiled 2002·Application pending·0 cites
- 3947US2022401380A1Cannabidiol compositions for use in treating heart conditionsCARDIOL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4046US2007238708A1Acute Inflammatory Condition TreatmentVASOGEN IRELAND LTD·Filed 2004·Application pending·0 cites
- 4146US2021085801A1Amphiphilic block copolymers, micelles, and methods for treating or preventing heart failureCARDIOL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4244US2007071805A1Treatment of inflammation and vascular abnormalities of the eyeVASOGEN IRELAND LTD·Filed 2006·Application pending·0 cites
- 4343US2007298020A1Apoptotic entities for use in treatment of endothelium dysfunction disordersVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 4442US2002090360A1Inflammatory cytokine secretion inhibitionFiled 2001·Application pending·0 cites
- 4542US2002090359A1Transforming growth factor regulationFiled 2001·Application pending·0 cites
- 4641US2006035809A1Apoptosis-mimicking natural vesicles and use thereof in medical treatmentBOLTON ANTHONY E·Filed 2002·Application pending·0 cites
- 4741US2008138432A1Acute Inflammatory Condition TreatmentVASOGEN IRELAND LTD·Filed 2005·Application pending·0 cites
- 4839US2006008517A1Treatment of age-related memory impairmentLYNCH MARINA A·Filed 2004·Application pending·0 cites
- 4937US6696092B2Endothelial lining effects and treatment of vasospastic disordersVASOGEN IRELAND LTD·Filed 1999·Granted Feb 24, 2004·3 cites·13 claims
- 5037US2004265927A1Apoptosis-mimicking synthetic entities and use thereof in medical treatmentFiled 2002·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anthony Bolton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →